EyeGate files for IPO

EyeGate Pharmaceuticals Inc. (Waltham, Mass.) filed to raise up to $28.8 million in an IPO on NASDAQ underwritten by Aegis. Last year, the company reported that transscleral iontophoresis delivery of ...